Biblio
Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9. Stem Cell Res. 2023;74:103284.
. Histone deacetylase 9 plays a role in sevoflurane-induced neuronal differentiation inhibition by inactivating cAMP-response element binding protein transcription and inhibiting the expression of neurotrophin-3. FASEB J. 2023;37(10):e23164.
. . . Establishment of a human iPSC (ZZUNEUi026-A) from a dilated cardiomyopathy patient carrying heterozygous Vinculin (c. 625A > T) mutant. Stem Cell Res. 2022;62:102812.
. Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant. Stem Cell Res. 2022;63:102836.
. An integration-free iPSC line ZZUNEUi028-A derived from a patient with hypertrophic cardiomyopathy carrying a heterozygous mutation (c. 1504 C > T) in MYBPC3 gene. Stem Cell Res. 2022;63:102848.
. Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 2022.
Reprogramming of a human induced pluripotent stem cell line (ZZUSAHi004-A) from a long QT syndrome patient with a heterozygous AKAP9 (c. 4021C > A) mutant. Stem Cell Res. 2022;65:102966.
. Toxicity of ceria nanoparticles to the regeneration of freshwater planarian Dugesia japonica: The role of biotransformation. Sci Total Environ. 2022:159590.
Generation of a hiPSC line ZZUNEUi017-A from a patient with dilated cardiomyopathy caused by mutation in TTN. Stem Cell Res. 2021;52:102248.
. Generation of a human iPSC line ZZUNEUi015-A from a patient with hypertrophic cardiomyopathy caused by mutation in ALPK3. Stem Cell Res. 2021;52:102247.
. Generation of an iPSC line (ZZUNEUi016-A) derived from a hypertrophic cardiomyopathy patient with the heterozygote mutation in MYH7 gene. Stem Cell Res. 2021;53:102262.
. Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation. Stem Cell Res. 2021;58:102622.
A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy. Stem Cell Res. 2021;51:102158.
. Induced pluripotent stem cell (iPSC) line (ZZUNEUi009-A) from a healthy female individual. Stem Cell Res. 2021;53:102275.
. An induced pluripotent stem cells line (ZZUNEUi022-A) derived from urine cells of healthy male human. Stem Cell Res. 2021;51:102191.
. Minimally Invasive Delivery of 3D Shape Recoverable Constructs with Ordered Structures for Tissue Repair. ACS Biomater Sci Eng. 2021.
. Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7. Stem Cell Res. 2020;43:101699.
Generation of a hiPSC line ZZUNEUi012-A from a healthy female individual. Stem Cell Res. 2020;50:102143.
Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system. Stem Cell Res. 2020;48:101930.
. Generation of an IPSC line from a patient with hypertrophic cardiomyopathy carrying a mutation in MYH6 gene. Stem Cell Res. 2020;50:102138.
. Generation of a human iPSC line from a patient with Marfan syndrome caused by mutation in FBN1. Stem Cell Res. 2019;36:101414.
.